Humanity is living in an interesting age, where scientists can finally start manipulating the human genome in ways that were not possible before due to CRISPR. Many have even hypothesized that through these amazing gene-editing tool, humans could become stronger, smarter, and all around better. Unfortunately, it could also lead to class warfare, an expert on genetics warns.
Dr. David King is a molecular biologist and is the founder of the watchdog group Human Genetics Alert. In a recent opinion piece published on The Guardian, Dr. King throws some cautious words at readers, warning them about the dangers of a blind race towards medical progress at the cost of everything else.
He is particularly keen on cautioning the public about genetic manipulation, especially when it no longer has anything to do with treating actual conditions. Dr. King explains that there are already plenty of ways to address genetic conditions among infants via early testing.
“Scientists who started their careers hoping to treat sick people and prevent suffering are now earning millions of dollars creating drugs to “enhance cognitive performance” or performing cosmetic surgery. We already have consumer eugenics in the US egg donor market, where ordinary working-class women get paid $5,000 for their eggs while tall, beautiful Ivy League students get $50,000. The free market effectively results in eugenics,” Dr. King writes.
Of course, for every person that shares Dr. King’s concerns, there are those who say that being able to tamper with genetic traits in babies is still a long way off. A researcher from Toronto’s Hospital for Sick Children, Dr. Janet Rossant said as much in another article published by The Guardian. According to her, designer babies are still not in the veil of reality as of right now.
“We are still a long way from serious consideration of using gene editing to enhance traits in babies,” Dr. Rossant explained. “We don’t understand the genetic basis of many of the human traits that might be targets for enhancement.”


Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
Neuralink Expands Brain Implant Trials with 12 Global Patients
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



